Piramal Enterprises is mulling to issue non-convertible debentures (NCDs) to raise up to Rs 500 crore. The company’s meeting of the Committee of Directors (Funding) will be held on January 05, 2016 to consider and approve the same.
Piramal Enterprises is one of the leading players globally in CRAMS (custom research and manufacturing services) as well as in the critical care segment of inhalation and injectable anaesthetics. It also has a strong presence in the OTC segment in India.